Back to Search Start Over

Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial.

Authors :
Wysham, W.Z.
Schaffer, E.M.
Coles, T.M.
Roque, D.R.
Wheeler, S.B.
Kim, K.H.
Source :
Gynecologic Oncology. Jun2016 Supplement 1, Vol. 141, p36-36. 1p.
Publication Year :
2016

Subjects

Subjects :
*BEVACIZUMAB
*OVARIAN cancer treatment
*OVARIAN cancer
*CANCER chemotherapy
*COST effectiveness
*PROGNOSIS

Details

Language :
English
ISSN :
00908258
Volume :
141
Database :
Academic Search Index
Journal :
Gynecologic Oncology
Publication Type :
Academic Journal
Accession number :
115918978
Full Text :
https://doi.org/10.1016/j.ygyno.2016.04.116
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details